CANNAMERICA BRANDS CORP. announce that on December 10, 2020, the Company has entered into a license application agreement with GA Bioscience Research Inc., a Georgia company formed for the purpose of obtaining a Cannabis licensure in the State of Georgia (the "License"). The License will allow GABRI to conduct business operations for the cultivation and manufacture of legal cannabis products for medical use. CannAmerica will be assisting GABRI by providing the Company's expertise for the license application and, if the license application is successful, providing services for the design, build, installation of equipment and launching the operations. Terms of the Agreement include: The initial term will be for the application window which will expire on December 28, 2020; Upon successful issuance of a License to GABRI, CannAmerica will provide expertise for the build-out of the project, equipment set-up, and training in all areas of cannabis cultivation, processing and manufacturing for a six-month term. The Agreement will be extended on a month-to-month basis until complete if the project continues past the six-month term; and The Company has a right of first refusal to enter into a separate licensing agreement with GABRI to bring the Company's branded products to the State of Georgia marketplace.